Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 31 3 2017
medline: 18 12 2019
entrez: 31 3 2017
Statut: ppublish

Résumé

Pulse pressure is a readily available vital sign that has been shown to independently predict outcomes in several cardiovascular disease states. We investigated the prognostic significance of pulse pressure (PP) and systolic blood pressure (SBP) among patients with acute coronary syndromes (ACS). A total of 14,514 patients with ACS in the prospective, multicentre Global Registry of Acute Coronary Events (GRACE), expanded GRACE (GRACE-2) and Canadian Registry of Acute Coronary Events (CANRACE) were stratified by initial PP on presentation. Patient characteristics and in-hospital outcomes were compared by PP quartiles and the independent prognostic significance of PP for in-hospital mortality was quantified. We compared the discriminative ability (c-statistic) of models incorporating either PP or SBP. Patients with higher PPs were older, more frequently female and had higher prevalence rates of conventional cardiovascular risk factors (all Higher presenting PP is associated with increased age and more prevalent cardiovascular risk factors, whereas patients with lower PP present with worse clinical characteristics and in-hospital outcomes. Lower PP is an independent adverse prognosticator in ACS. However, PP did not improve the discriminatory performance of the GRACE risk score compared with SBP.

Sections du résumé

BACKGROUND BACKGROUND
Pulse pressure is a readily available vital sign that has been shown to independently predict outcomes in several cardiovascular disease states. We investigated the prognostic significance of pulse pressure (PP) and systolic blood pressure (SBP) among patients with acute coronary syndromes (ACS).
METHODS METHODS
A total of 14,514 patients with ACS in the prospective, multicentre Global Registry of Acute Coronary Events (GRACE), expanded GRACE (GRACE-2) and Canadian Registry of Acute Coronary Events (CANRACE) were stratified by initial PP on presentation. Patient characteristics and in-hospital outcomes were compared by PP quartiles and the independent prognostic significance of PP for in-hospital mortality was quantified. We compared the discriminative ability (c-statistic) of models incorporating either PP or SBP.
RESULTS RESULTS
Patients with higher PPs were older, more frequently female and had higher prevalence rates of conventional cardiovascular risk factors (all
CONCLUSION CONCLUSIONS
Higher presenting PP is associated with increased age and more prevalent cardiovascular risk factors, whereas patients with lower PP present with worse clinical characteristics and in-hospital outcomes. Lower PP is an independent adverse prognosticator in ACS. However, PP did not improve the discriminatory performance of the GRACE risk score compared with SBP.

Identifiants

pubmed: 28357882
doi: 10.1177/2048872617700871
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-317

Auteurs

Nigel S Tan (NS)

1 Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Bradley Sarak (B)

1 Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Keith Aa Fox (KA)

2 Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK.

David Brieger (D)

3 Concord Hospital, University of Sydney, Sydney, Australia.

Ph Gabriel Steg (PG)

4 FACT (French Alliance for Cardiovascular Trials), Département Hospitalo-Universitaire FIRE, Université Paris Diderot, AP-HP, Hôpital Bichat, Paris, France.
5 INSERM U-1148, Paris, France.

Chris P Gale (CP)

6 Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

Deepak L Bhatt (DL)

7 Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Frederick A Spencer (FA)

8 Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.

Francois R Grondin (FR)

9 Hôtel-Dieu de Lévis, Lévis, QC, Canada.

Shaun G Goodman (SG)

1 Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
10 Canadian Heart Research Centre, Toronto, ON, Canada.

Andrew T Yan (AT)

1 Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH